EDGAR Filing Documents for 0001193125-23-001193

Form 8-K - Current report:

SEC Accession No. 0001193125-23-001193

Filing Date

2023-01-04

Accepted

2023-01-04 07:12:03

Documents

Period of Report

2023-01-02

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d445531d8k.htm iXBRL	8-K	33672
2	EX-99.1	d445531dex991.htm	EX-99.1	24931
3	EX-99.2	d445531dex992.htm	EX-99.2	13671
7	GRAPHIC	g445531ex99_2s10g1.jpg	GRAPHIC	264225
8	GRAPHIC	g445531ex99_2s11g1.jpg	GRAPHIC	321070
9	GRAPHIC	g445531ex99_2s12g1.jpg	GRAPHIC	313867
10	GRAPHIC	g445531ex99_2s13g1.jpg	GRAPHIC	279177
11	GRAPHIC	g445531ex99_2s14g1.jpg	GRAPHIC	234379
12	GRAPHIC	g445531ex99_2s15g1.jpg	GRAPHIC	251848
13	GRAPHIC	g445531ex99_2s16g1.jpg	GRAPHIC	233822
14	GRAPHIC	g445531ex99_2s1g1.jpg	GRAPHIC	211861
15	GRAPHIC	g445531ex99_2s2g1.jpg	GRAPHIC	455601
16	GRAPHIC	g445531ex99_2s3g1.jpg	GRAPHIC	276297
17	GRAPHIC	g445531ex99_2s4g1.jpg	GRAPHIC	100063
18	GRAPHIC	g445531ex99_2s5g1.jpg	GRAPHIC	281732
19	GRAPHIC	g445531ex99_2s6g1.jpg	GRAPHIC	314579
20	GRAPHIC	g445531ex99_2s7g1.jpg	GRAPHIC	227309
21	GRAPHIC	g445531ex99_2s8g1.jpg	GRAPHIC	388473
22	GRAPHIC	g445531ex99_2s9g1.jpg	GRAPHIC	246214
23	GRAPHIC	g445531g0104065158439.jpg	GRAPHIC	2838
	Complete submission text file	0001193125-23-001193.txt		6277246

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	fulc-20230102.xsd	EX-101.SCH	2855
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	fulc-20230102_lab.xml	EX-101.LAB	17977
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	fulc-20230102_pre.xml	EX-101.PRE	11261
25	EXTRACTED XBRL INSTANCE DOCUMENT	d445531d8k_htm.xml	XML	3353

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139

Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851

Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)